The Sydney Diabetes Prevention Program: A community-based translational study by Colagiuri, Stephen et al.
Colagiuri et al. BMC Public Health 2010, 10:328
http://www.biomedcentral.com/1471-2458/10/328
Open Access STUDY PROTOCOL
© 2010 Colagiuri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Study protocol The Sydney Diabetes Prevention Program: A 
community-based translational study
Stephen Colagiuri*1, Philip Vita2, Magnolia Cardona-Morrell2, Maria Fiatarone Singh3, Louise Farrell2, Andrew Milat4, 
Marion Haas5 and Adrian Bauman6
Abstract
Background: Type 2 diabetes is a major public health problem in Australia with prevalence increasing in parallel with 
increasing obesity. Prevention is an essential component of strategies to reduce the diabetes burden. There is strong 
and consistent evidence from randomised controlled trials that type 2 diabetes can be prevented or delayed through 
lifestyle modification which improves diet, increases physical activity and achieves weight loss in at risk people. The 
current challenge is to translate this evidence into routine community settings, determine feasible and effective ways 
of delivering the intervention and providing on-going support to sustain successful behavioural changes.
Methods/Design: The Sydney Diabetes Prevention Program (SDPP) is a translational study which will be conducted in 
1,550 participants aged 50-65 years (including 100 indigenous people aged 18 years and older) at high risk of future 
development of diabetes. Participants will be identified through a screening and recruitment program delivered 
through primary care and will be offered a community-based lifestyle modification intervention. The intervention 
comprises an initial individual session and three group sessions based on behaviour change principles and focuses on 
five goals: 5% weight loss, 210 min/week physical activity (aerobic and strength training exercise), limit dietary fat and 
saturated fat to less than 30% and 10% of energy intake respectively, and at least 15 g/1000 kcal dietary fibre. This is 
followed by 3-monthly contact with participants to review progress and offer ongoing lifestyle advice for 12 months. 
The effectiveness and costs of the program on diabetes-related risk factors will be evaluated. Main outcomes include 
changes in weight, physical activity, and dietary changes (fat, saturated fat and fibre intake). Secondary outcomes 
include changes in waist circumference, fasting plasma glucose, blood pressure, lipids, quality of life, psychological well 
being, medication use and health service utilization.
Discussion: This translational study will ascertain the reach, feasibility, effectiveness and cost-effectiveness of a lifestyle 
modification program delivered in a community setting through primary health care. If demonstrated to be effective, it 
will result in recommendations for policy change and practical methods for a wider community program for 
preventing or delaying the onset of type 2 diabetes in high risk people.
Background
The number of people developing type 2 diabetes is rising
dramatically worldwide with 439 million cases projected
by 2030 [1]. This trend is mirrored in Australia where the
prevalence of diabetes has more than doubled between
1981 and 2000 [2]. Currently in Australia there are over 1
million people with type 2 diabetes and approximately 8
per 1,000 people aged 25 years and older develop diabetes
each year [3]. The annual health care costs in Australia of
type 2 diabetes have been estimated at $2.2 billion AUD
[4].
The increasing prevalence of diabetes, the increase in
modifiable risk factors for the disease (obesity, sedentary
behaviour and poor nutritional choices), as well as the
severe and costly complications which can be difficult to
prevent and treat, mean that prevention is an important
strategy for reducing the burden of diabetes.
There is strong and consistent evidence from ran-
domised controlled trials that type 2 diabetes can be pre-
vented or delayed through lifestyle modification
interventions which aim to improve diet, increase physi-
cal activity and reduce weight in people at high risk of
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developing the disease. The Finnish [5] and US [6] studies
achieved a 58% reduction in diabetes incidence through
lifestyle modification while the Chinese Da Qing study [7]
achieved a 40% reduction in type 2 diabetes. Both the
Finnish [8] and Chinese studies [9] showed long-term
persistence of reduced diabetes risk over 7 and 20 years
respectively. Similar benefits have been shown in the Jap-
anese [10] and Indian [11] diabetes prevention trials, sug-
gesting the generalisability of these findings.
Diabetes prevention programs recognise the impor-
tance of a theoretically-grounded behavioural interven-
tion as a core component of the lifestyle modification,
although no single behavioural theory has dominated.
The behavioural programs have focused on encouraging
physical activity and dietary changes and included vari-
ous components such as initial assessment, individualised
goal setting, individual counseling, on-going support,
regular assessment and feedback and monitoring of
behaviours and outcomes throughout the study.
Small community-based programs have reported some
success in modifying surrogate markers for diabetes
through lifestyle intervention. The Greater Green Trian-
gle Diabetes Prevention Project in Australia [12] and the
Good Ageing in Lahti Region Lifestyle Implementation
Trial in Finland [13] confirmed that short-term lifestyle
modification programs can reduce risk factors for diabe-
tes in primary care settings.
The current challenge is to translate this evidence into
cost-effective large scale community-wide programs.
There is increasing acknowledgement that the best way
to do this is through studies which have an explicit focus
on generalisation and feasibility and which report infor-
m a t i o n  o n  c o n t e x t u a l  v a r i a b l e s  s u c h  a s  r e p r e s e n t a t i v e -
ness, reach, implementation and adaption, costs and
other outcomes important to policy makers [14]. Thus
the current study employs a design which will not only
provide data on intervention effectiveness, but also will
examine contextual factors through process evaluation
central to what has been called by some the 'science of
delivery' [15].
The overall aim of this study is to assess the effective-
ness of a community-based lifestyle modification pro-
g r a m  o n  m o d i f i a b l e  r i s k  f a c t o r s  f o r  t y p e  2  d i a b e t e s .
Additional aims include assessing the feasibility of deliv-
ering the program in a primary health care setting; identi-
fying determinants of the interventions which are
associated with and predict a beneficial outcome; and the
costs and cost-effectiveness of the program.
Methods/Design
The SDPP is a translational study based on the active arm
of international randomised controlled trials demonstrat-
ing the effectiveness of lifestyle modification interven-
tions in reducing the incidence or delaying the onset of
type 2 diabetes in high risk individuals.
Setting
Communities in three Divisions of General Practice, one
in metropolitan Sydney, one in a semi-rural area and the
other in a rural area of NSW, Australia.
Ethics
Ethics approval to conduct this trial has been granted by
the Research Ethics Review Committee of the Sydney
South West Area Health Service - Eastern Zone (ID
Number X08-0053). Written informed consent is
obtained by all participants prior to enrolment.
Participants and recruitment
The Divisions of General Practice have recruited over 75
practices and 150 general practitioners (GPs) to partici-
pate in the study. This was done through expression of
interest by letter and fax, information sessions and site
visits. The main pre-requisite for inclusion was the prac-
tice having a computerised patient record system.
People aged 50-65 years (18 years and older in the
indigenous subgroup) without known diabetes attending
study general practices are approached to participate. A
variety of methods are used to identify potential partici-
pants including opportunistic recruitment when the per-
son attends the general practitioner for a routine
consultation, using the practice's computer database to
identify people in the target age range and sending a let-
ter suggesting they attend for risk assessment, and local
media advertising of the program.
Risk is assessed using the AUSDRISK tool, a question-
naire developed in Australia [16]. The questions focus on
demographic and diabetes risk factors and include an
objective assessment of waist circumference performed
by trained research staff. The maximum AUSDRISK
score is 38 and a score of ≥ 15 is considered high risk. A
score of 15-19 is associated with a 1 in 7 chance and a
score of ≥ 20 with a 1 in 3 chance of developing diabetes
over the next 5 years [16]. A score of ≥ 12 is considered
high risk in the indigenous subgroup.
A person with a risk score of ≥ 15 is required to
undergo investigations to exclude prevalent diabetes.
This initially involves measurement of capillary blood
glucose in the general practitioner's surgery, followed by
measurement of fasting plasma glucose and possibly an
oral glucose tolerance test.
Study exclusion criteria include new or previously diag-
nosed diabetes, taking a hypoglycaemic medication in the
past month, use of prescribed weight loss medication or a
medical contraindication to participation in a physical
activity program. Participants enter the study after writ-
ten consent is obtained, eligibility criteria have been met
and clearance is received from their general practitioner.Colagiuri et al. BMC Public Health 2010, 10:328
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The study plans to recruit 1,550 high risk people into
the lifestyle intervention program. Among these 100 will
be Arabic-speaking, 100 will be Chinese-speaking and
100 will be indigenous people.
Intervention - Lifestyle Modification Program
The five aims of the lifestyle modifications are:
1. At least 30 min/day of moderate to vigorous intensity
physical activity, including aerobic exercise 3 or more
days/week plus strength training at least twice/week (210
min/week total structured exercise)
2. Reduction in the intake of energy from total fat to
less than 30%
3. Reduction in the intake of energy from saturated fat
to less than 10%
4. Fibre intake of at least 15 g/1000 kcal
5. Achievement of a 5% reduction in body weight at 12
months.
In addition to the 210 min/week structured exercise
goal, participants are encouraged to increase incidental
physical activity in ways which would enhance both car-
diovascular and musculoskeletal fitness.
These five goals are entirely concordant with the Finn-
ish DPS (5), which was one of the most successful diabe-
tes prevention trials. The physical activity goal, which has
been modified slightly from the Finnish DPS is based on a
review of the physical activity prescriptions utilised in
relation to outcomes achieved in all of the successful tri-
als of diabetes prevention (5,6,7,10,11), considerations of
cost and feasibility in this translational setting, as well as
other literature regarding modality, volume, and intensity
of exercise required to improve metabolic risk and body
composition in similar cohorts. Both the Finnish DPS and
the US DPP included resistance training (strength train-
ing) in their supervised exercise sessions and is explicitly
specified within the physical activity goal of the SDPP.
Resistance training is an anabolic form of exercise, differ-
ing substantially from aerobic exercise in its ability to
induce muscle hypertrophy and associated metabolic and
functional changes [17,18]. It improves insulin sensitivity,
glucose homeostasis, blood pressure, dyslipidaemia,
markers of inflammation and catabolism, and visceral
obesity, thus addressing the key metabolic abnormalities
in adults at high risk of type 2 diabetes [19,20]. Impor-
tantly, resistance training (but not aerobic exercise) atten-
uates or prevents the loss of lean tissue (muscle and bone)
accompanying weight loss diets such as those prescribed
in this study [21].
The behavioural components are based on stages of
change [22] and social cognitive theories [23]. The inter-
vention is delivered by dedicated program lifestyle offi-
cers from a variety of health backgrounds including
dietetics, nursing, psychology and exercise physiology.
The lifestyle officers undergo specific training in health
coaching, group program delivery and standardized data
collection used for evaluation. The health coaching
approach incorporates principles from self-management,
removing psychological blocks to change and confidence
[24].
An overview of the program and the evaluation plan is
shown in Figure 1.
High risk individuals agreeing to participate in the life-
style modification program complete an initial computer-
assisted telephone interview (CATI) survey. This survey
includes socio-economic and demographic information,
physical activity habits, quality of life, and self-efficacy, as
well as recent health service utilisation and current medi-
cation use. Participants are then scheduled to attend an
individual consultation with a lifestyle officer. At this con-
sultation, the lifestyle officers measure height, weight and
waist circumference using calibrated stadiometers, scales
and tape measures, following a standardized anthropo-
metric protocol as specified by the International Society
for the Advancement of Kinanthropometry (ISAK) [25].
The individual consultation includes a general discussion
about diabetes risk and prevention, an overview of the
program, and uses motivational interviewing techniques
to assist participants to set goals and develop tools to self-
Figure 1 Overview of the program and data collection points for 
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monitor. Following this session, arrangements are made
for participants to attend three two-hour group programs
held over a six to eight week period. Lifestyle officers con-
duct these group sessions of approximately 10 people,
which cover theoretical, behavioural and practical
aspects of diet and physical activity. The overall program
motto is: "Eat better and move more". Those who are not
able to or do not want to attend a group program are
offered the option of three individual health coaching ses-
sions by telephone, covering the same material. The
intervention delivered to indigenous participants will be
slightly modified to take account of cultural issues.
Follow up telephone calls are made by the lifestyle offi-
cers to each participant at 3, 6 and 9 months to enquire
about progress, assist with behaviour change and offer
participants additional support as required.
In addition, participants are provided with details of
local community-based lifestyle programs which have
been evaluated by the research staff and found to be con-
sistent with the goals of the SDPP. Participants have the
option of enrolling in such programs as one way to assist
in achieving the SDPP physical activity and dietary goals.
At 12 months the CATI survey is repeated and partici-
pants undergo an individual assessment with the lifestyle
officer and their general practitioner.
Outcome measures and evaluation plan
The evaluation plan has three components:
1. Impact evaluation measures changes at 12 months in
the key outcomes known to be associated with reduced
diabetes incidence: weight loss; increase in moderate to
vigorous physical activity (including both aerobic and
strengthening activities); increase in dietary fibre con-
sumption; decrease in fat consumption and decrease in
saturated fat intake. Program and participant factors
which predict these outcomes are assessed.
2. Process evaluation measures program reach, fidelity,
satisfaction and knowledge of program delivery by staff,
satisfaction of consumers, and identifies facilitators and
barriers associated with program implementation and
delivery.
3. Economic evaluation involves health system and
individual perspectives and estimates implementation
costs, costs per outcome and cost-effectiveness.
Impact Evaluation
Outcomes are assessed at baseline and 12 months by
research staff, using a combination of in-person assess-
ment and CATI questionnaires. Physical activity is
assessed using the Physical Activity Scale for the Elderly
(PASE), which has established reliability and validity [26].
Dietary intake (including total fat, saturated fat and fibre)
is assessed by a self-completed 3-day non-weighed food
record, which is analysed using Foodworks [27].
Weight, height, waist circumference and blood pressure
are measured using standard methods. Blood is collected
for measurement of fasting plasma glucose and lipids.
Additional questions on socio-demographic characteris-
tics, concomitant diseases and medications, smoking,
alcohol, social support, self-efficacy for lifestyle change,
and quality of life are asked at the baseline and 12 month
CATI surveys.
Analyses of these data will determine whether the pro-
gram goals are achieved by individuals, by the group as a
whole and differentially by sub-groups (e.g. GP Division
and gender). In addition, these data will be used to model
the projected impact of the program beyond the 12-
month intervention period.
Process Evaluation
This is a central component of the evaluation of this
translational study in order to assess whether the pro-
gram is implemented as planned, achieves population
reach and whether it is feasible in the primary care field
setting. Details of the process evaluation components are
shown in Table 1.
Economic Evaluation
The economic evaluation will adopt a health system per-
spective by measuring costs at Area Health Service, Gov-
ernment and general practice levels. It will also use a
limited societal perspective by measuring direct costs to
participants. In addition, the estimated costs of a state-
wide rollout of the SDPP will be reported. The base cost
year will be 2008. No discounting will be applied as this is
a 12-month program including intervention and follow-
up.
The economic evaluation will compare the cost of pro-
gram implementation with its intermediate outcomes.
The results of the study will be used to build a model of
future costs and effects beyond the study period using
Australian population and risk factor data [28-32]. Infor-
mation to be collected about resource use will include
program expenses (e.g. cost of screening and delivering
the intervention), individual level and health system
expenditure data. These will include direct health-related
costs (visits to health professionals, hospitalisation, medi-
cation use etc) and direct non-health costs (gym sub-
scription, exercise equipment, etc.) relevant to diabetes
prevention, and indirect costs (e.g. sick days). This infor-
mation will allow estimation of the cost per estimated
case of diabetes prevented and cost per outcome (e.g. cost
per kg weight loss; cost per change in additional time of
physical activity, etc). Modelling will project these calcu-
lations beyond the study period using lives saved, life-
years saved and quality-adjusted life-years (QALYs)
gained to calculate the benefits associated with this pro-
gram.Colagiuri et al. BMC Public Health 2010, 10:328
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Statistical methods
Analysis at 12 months will determine the extent that pro-
gram goals were achieved, through overall and sub-group
analysis. Primary outcomes which will be reported
include weight loss (and 5% weight loss goal achieve-
ment), physical activity levels (in minutes per week of
overall intentional activity, and sessions per week of
strength training) and PASE scores, dietary measures
(total energy/day, estimated fibre intake (gm/1,000 kcal),
total fat intake (gm/day), fat as a proportion of total
energy intake and saturated fat as a proportion of daily
energy intake), and proportions of the cohort achieving
1,2,3,4, or all 5 goals. Logistic regression analysis will be
used to examine factors associated with the achievement
of program goals. Separate models will examine predic-
tors of 5% weight loss, achievement of 210 min/day of
physical activity, and achievement of dietary goals.
Missing data due to either refusal to respond to selected
questions or withdrawal from the program before the
endpoint will be dealt with by imputing values for the dis-
crepant self-reports using data from "similar" participants
or using last observation carried forward (LOCF) tech-
niques when appropriate.
A minimal sample size of 1,000 completed participants
with baseline and 12 month data will provide 90% power
to detect small differences in primary outcomes effects at
the 5% level of confidence for the whole group. Specifi-
cally, we will be able to detect:
• 5% weight loss
• increase of 2.5 g of fibre/1,000 kcal
• 3.4% reduction of fat intake as a percentage of total 
energy
• 2.7% reduction of saturated fat intake as a percent-
age of total fat intake
• 11.7 min/wk of increased physical activity.
Discussion
Lifestyle modification has been shown to effectively
reduce the risk of incident diabetes in randomised con-
trolled trials. The main challenge is to translate this evi-
dence into a routine community-wide setting and provide
a feasible, effective and cost-effective intervention. The
current study is designed to address these presently
unanswered public health and policy-relevant questions.
The information gathered in this study will be of direct
relevance to the design, implementation and affordability
of community-wide diabetes prevention programs
throughout Australia and other countries with a well-
developed health care system. The key questions which
can be addressed by the SDPP relate to the delivery,
effects, costs and structure of community-based lifestyle
modification programs, including key barriers and facili-
tators and key determinants of process and impact out-
comes. Importantly, the study should provide a better
understanding of the interplay of these factors in real-
world settings in metropolitan, regional and rural settings
across populations of differing socioeconomic status and
ethnic background and by doing so increase the general-
isability of the findings. Answers to these issues are of
direct relevance to future local, national, and interna-
tional evidence-based policy and practice with regard to
prevention of diabetes and lifestyle-related chronic dis-
eases. The study will also provide an understanding of the
preferences of participants for lifestyle-related strategies
Table 1: Process evaluation components in the Sydney Diabetes Prevention Program
Evaluation Component Data source and format Timeframe
Screening, participation and recruitment rates Administrative documentation from Divisions 
of General Practice
Ongoing during recruitment
Program fidelity, program completion, intervention 
completed
Participants' database Ongoing
Assessment of practice staff awareness and engagement 
with program
Telephone administered questionnaires to 
selected doctors and practice staff
Ongoing
Barriers to recruitment, and program delivery In-depth-interviews and focus groups with 
practice staff
Ongoing
Challenges in program delivery and patient maintenance 
in program.
Focus group with lifestyle officers Ongoing
Participants' barriers to attendance at group sessions From participants via the Lifestyle Officers Three months after group sessions 
completed
Number and type of organisations participating, 
perceived level of collaboration, barriers and success 
factors for community-based programs/services for 
physical activity and weight management
In-depth-interviews and focus groups with key 
stakeholders
Towards the end of the Program, 
when 12 month follow up data 
availableColagiuri et al. BMC Public Health 2010, 10:328
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and programs, which will also be relevant to the design of
future strategies and programs.
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Program.
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